These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 15081152

  • 1. Transdermal delivery of phosphorodiamidate Morpholino oligomers across hairless mouse skin.
    Pannier AK, Arora V, Iversen PL, Brand RM.
    Int J Pharm; 2004 May 04; 275(1-2):217-26. PubMed ID: 15081152
    [Abstract] [Full Text] [Related]

  • 2. Antisense phosphorodiamidate morpholino oligomer length and target position effects on gene-specific inhibition in Escherichia coli.
    Deere J, Iversen P, Geller BL.
    Antimicrob Agents Chemother; 2005 Jan 04; 49(1):249-55. PubMed ID: 15616302
    [Abstract] [Full Text] [Related]

  • 3. Transdermal drug delivery using microemulsion and aqueous systems: influence of skin storage conditions on the in vitro permeability of diclofenac from aqueous vehicle systems.
    Sintov AC, Botner S.
    Int J Pharm; 2006 Mar 27; 311(1-2):55-62. PubMed ID: 16431047
    [Abstract] [Full Text] [Related]

  • 4. In vitro transdermal delivery of caffeine, theobromine, theophylline and catechin from extract of Guarana, Paullinia Cupana.
    Heard CM, Johnson S, Moss G, Thomas CP.
    Int J Pharm; 2006 Jul 06; 317(1):26-31. PubMed ID: 16600539
    [Abstract] [Full Text] [Related]

  • 5. Antisense peptide-phosphorodiamidate morpholino oligomer conjugate: dose-response in mice infected with Escherichia coli.
    Tilley LD, Mellbye BL, Puckett SE, Iversen PL, Geller BL.
    J Antimicrob Chemother; 2007 Jan 06; 59(1):66-73. PubMed ID: 17079242
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics and biodistribution of phosphorodiamidate morpholino antisense oligomers.
    Amantana A, Iversen PL.
    Curr Opin Pharmacol; 2005 Oct 06; 5(5):550-5. PubMed ID: 16087398
    [Abstract] [Full Text] [Related]

  • 7. Moisturizing lotions can increase transdermal absorption of the herbicide 2,4-dichlorophenoxacetic acid across hairless mouse skin.
    Brand RM, Charron AR, Sandler VL, Jendrzejewski JL.
    Cutan Ocul Toxicol; 2007 Oct 06; 26(1):15-23. PubMed ID: 17464745
    [Abstract] [Full Text] [Related]

  • 8. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM, Corish J, Corrigan OI, Fitzpatrick D.
    Int J Pharm; 2007 Aug 16; 341(1-2):114-24. PubMed ID: 17502130
    [Abstract] [Full Text] [Related]

  • 9. Identification of penetration enhancers for testosterone transdermal delivery from spray formulations.
    Leichtnam ML, Rolland H, Wüthrich P, Guy RH.
    J Control Release; 2006 Jun 12; 113(1):57-62. PubMed ID: 16677734
    [Abstract] [Full Text] [Related]

  • 10. Microemulsions as transdermal drug delivery vehicles.
    Kogan A, Garti N.
    Adv Colloid Interface Sci; 2006 Nov 16; 123-126():369-85. PubMed ID: 16843424
    [Abstract] [Full Text] [Related]

  • 11. Arginine-rich peptide conjugation to morpholino oligomers: effects on antisense activity and specificity.
    Nelson MH, Stein DA, Kroeker AD, Hatlevig SA, Iversen PL, Moulton HM.
    Bioconjug Chem; 2005 Nov 16; 16(4):959-66. PubMed ID: 16029037
    [Abstract] [Full Text] [Related]

  • 12. Discovery of transdermal penetration enhancers by high-throughput screening.
    Karande P, Jain A, Mitragotri S.
    Nat Biotechnol; 2004 Feb 16; 22(2):192-7. PubMed ID: 14704682
    [Abstract] [Full Text] [Related]

  • 13. Alteration of skin hydration and its barrier function by vehicle and permeation enhancers: a study using TGA, FTIR, TEWL and drug permeation as markers.
    Shah DK, Khandavilli S, Panchagnula R.
    Methods Find Exp Clin Pharmacol; 2008 Sep 16; 30(7):499-512. PubMed ID: 18985178
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of transdermal delivery of progesterone using medium-chain mono and diglycerides as skin penetration enhancers.
    Lopes LB, Murphy N, Nornoo A.
    Pharm Dev Technol; 2009 Sep 16; 14(5):524-9. PubMed ID: 19552564
    [Abstract] [Full Text] [Related]

  • 15. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
    Aboofazeli R, Zia H, Needham TE.
    Drug Deliv; 2002 Sep 16; 9(4):239-47. PubMed ID: 12511202
    [Abstract] [Full Text] [Related]

  • 16. Topical and transdermal delivery of antisense oligonucleotides.
    Brand RM.
    Curr Opin Mol Ther; 2001 Jun 16; 3(3):244-8. PubMed ID: 11497348
    [Abstract] [Full Text] [Related]

  • 17. The effects of vehicle and region of application on in vitro penetration of testosterone through canine skin.
    Mills PC, Magnusson BM, Cross SE.
    Vet J; 2006 Mar 16; 171(2):276-80. PubMed ID: 16490709
    [Abstract] [Full Text] [Related]

  • 18. Transdermal absorption of radioprotectors using permeation-enhancing vehicles.
    Sodicoff M, Lamperti A, Ziskin MC.
    Radiat Res; 1990 Feb 16; 121(2):212-9. PubMed ID: 2154835
    [Abstract] [Full Text] [Related]

  • 19. Formulation and in vitro/in vivo evaluation of levodopa transdermal delivery systems.
    Lee KE, Choi YJ, Oh BR, Chun IK, Gwak HS.
    Int J Pharm; 2013 Nov 18; 456(2):432-6. PubMed ID: 24008082
    [Abstract] [Full Text] [Related]

  • 20. Effect of choline esters and oleic acid on the penetration of acyclovir, estradiol, hydrocortisone, nitroglycerin, retinoic acid and trifluorothymidine across hairless mouse skin in vitro.
    Loftsson T, Somogyi G, Bodor N.
    Acta Pharm Nord; 1989 Nov 18; 1(5):279-86. PubMed ID: 2514720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.